Analyst Price Targets — GMED
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 28, 2026 10:43 am | — | UBS | $82.00 | $78.25 | TheFly | Globus Medical initiated with a Neutral at UBS |
| July 16, 2026 2:04 pm | Richard Newitter | Truist Financial | $100.00 | $80.85 | TheFly | Globus Medical price target lowered to $100 from $115 at Truist |
| July 13, 2026 1:15 pm | Shagun Singh | RBC Capital | $115.00 | $79.53 | TheFly | Globus Medical price target lowered to $115 from $120 at RBC Capital |
| July 8, 2026 8:17 pm | — | BMO Capital | $94.00 | $76.20 | TheFly | Globus Medical initiated with an Outperform at BMO Capital |
| July 8, 2026 11:21 am | — | Stifel Nicolaus | $80.00 | $78.83 | StreetInsider | Globus Medical (GMED) PT Lowered to $80 at Stifel on 'Modest Upside Potential'Member Login |
| June 15, 2026 10:38 am | — | Piper Sandler | $100.00 | $80.39 | TheFly | Globus Medical price target lowered to $100 from $115 at Piper Sandler |
| May 8, 2026 1:46 pm | — | Needham | $117.00 | $78.77 | TheFly | Globus Medical price target raised to $117 from $114 at Needham |
| May 8, 2026 11:47 am | Larry Biegelsen | Wells Fargo | $103.00 | $85.08 | TheFly | Globus Medical price target lowered to $103 from $104 at Wells Fargo |
| February 25, 2026 2:37 pm | Richard Newitter | Truist Financial | $115.00 | $94.32 | TheFly | Globus Medical price target raised to $115 from $105 at Truist |
| January 30, 2026 11:46 am | — | Needham | $112.00 | $90.22 | TheFly | Globus Medical upgraded to Buy from Hold at Needham |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for GMED

Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.

The mean of analysts' price targets for Globus Medical (GMED) points to a 25% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Integer (ITGR). But which of these two stocks is more attractive to value investors?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

American Capital Management Inc. acquired a new stake in shares of Globus Medical, Inc. (NYSE: GMED) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 653,072 shares of the medical device company's stock, valued at approximately $51,599,000. Globus Medical
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
